Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yang

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Neurobiology of Disease|October 22, 2013
Evidence that collaboration between HIF-1α and Notch-1 promotes neuronal cell death in ischemic strokeYi-Lin Cheng, Jong-Sung Park, Silvia Manzanero, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
Journal of the American College of Radiology : JACR|August 21, 2022
Utility and Costs During the Initial Year of 3D Printing in an Academic HospitalPrashanth Ravi, Michael B Burch, Shayan Farahani, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Cell Genomics|May 27, 2026
A protein interactome for the last eukaryotic common ancestor illuminates the biochemical basis of modern genetic diseasesRachael M Cox, Ophelia Papoulas, Shirlee Shril, et al.
Science (New York, N.Y.)|September 16, 2017
Fabrication of fillable microparticles and other complex 3D microstructuresKevin J McHugh, Thanh D Nguyen, Allison R Linehan, et al.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Blood|November 6, 2016
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemiaJingfang Zhang, Guangyao Kong, Adhithi Rajagopalan, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Neurobiology of Disease|October 22, 2013
Evidence that collaboration between HIF-1α and Notch-1 promotes neuronal cell death in ischemic strokeYi-Lin Cheng, Jong-Sung Park, Silvia Manzanero, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
Journal of the American College of Radiology : JACR|August 21, 2022
Utility and Costs During the Initial Year of 3D Printing in an Academic HospitalPrashanth Ravi, Michael B Burch, Shayan Farahani, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Cell Genomics|May 27, 2026
A protein interactome for the last eukaryotic common ancestor illuminates the biochemical basis of modern genetic diseasesRachael M Cox, Ophelia Papoulas, Shirlee Shril, et al.
Science (New York, N.Y.)|September 16, 2017
Fabrication of fillable microparticles and other complex 3D microstructuresKevin J McHugh, Thanh D Nguyen, Allison R Linehan, et al.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Blood|November 6, 2016
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemiaJingfang Zhang, Guangyao Kong, Adhithi Rajagopalan, et al.
Pageof 19